Searchable abstracts of presentations at key conferences in endocrinology

ea0051p045 | Pituitary and growth | BSPED2017

Growth hormone secreting adenomas and the challenges of treatment in children

Iyer Dhaara , Kershaw Melanie , Karavitaki Niki , Walsh Richard , Adamski Jenny , Korbonits Marta , Dias Renuka

Introduction: In children, tumours occupying the pituitary fossa are mainly craniopharyngioma (80–90%) and pituitary adenomas (2–3%). We present two cases of pituitary adenoma and the challenging management when complete surgical resection is not possible. Case 1: A 13.5 year old girl presented with tall stature. Pituitary hormone profile revealed high IGF1 123 nmol/l (24.5–66) and prolactin 722 mU/l (102–496). Growth hormone (GH) was not completely suppres...

ea0050oc1.6 | Early Career Oral Communications | SFEBES2017

Investigating the role of AIP in mouse pituitary adenoma formation

Solomou Antonia , Herincs Maria , Roncaroli Federico , Vignola Maria Lillina , Gaston-Massuet Carles , Korbonits Marta

Introduction: Mutations in the aryl hydrocarbon receptor-interacting protein (AIP) predispose humans to pituitary adenomas, mostly GH and sometimes prolactin-secreting adenomas. Rodent models of heterozygous AIP loss provided mixed results, with little phenotype in heterozygote global knockouts to 80% in somatotroph-specific homozygote knockout animals. However, human patients with an AIP mutation often have mixed GH-PRL adenomas and, in a smaller pr...

ea0050cc03 | Featured Clinical Cases | SFEBES2017

A novel variant in the androgen receptor gene causing familial mild androgen insensitivity syndrome

Iacovazzo Donato , Kumar Ajith , Abbs Stephen , Solomon Andrew , Korbonits Marta , Druce Maralyn

Introduction: Androgen insensitivity syndrome (AIS) is a heterogeneous condition. At the milder end of the clinical spectrum, patients with mild AIS (MAIS) are phenotypically male, and may present with infertility, either isolated or associated with gynaecomastia or signs of mild undervirilization. Most cases of complete and approximately 25% of partial AIS patients harbour mutations in the androgen receptor (AR) gene. Over 1,000 pathogenic variants have been describe...

ea0050oc1.6 | Early Career Oral Communications | SFEBES2017

Investigating the role of AIP in mouse pituitary adenoma formation

Solomou Antonia , Herincs Maria , Roncaroli Federico , Vignola Maria Lillina , Gaston-Massuet Carles , Korbonits Marta

Introduction: Mutations in the aryl hydrocarbon receptor-interacting protein (AIP) predispose humans to pituitary adenomas, mostly GH and sometimes prolactin-secreting adenomas. Rodent models of heterozygous AIP loss provided mixed results, with little phenotype in heterozygote global knockouts to 80% in somatotroph-specific homozygote knockout animals. However, human patients with an AIP mutation often have mixed GH-PRL adenomas and, in a smaller pr...

ea0050cc03 | Featured Clinical Cases | SFEBES2017

A novel variant in the androgen receptor gene causing familial mild androgen insensitivity syndrome

Iacovazzo Donato , Kumar Ajith , Abbs Stephen , Solomon Andrew , Korbonits Marta , Druce Maralyn

Introduction: Androgen insensitivity syndrome (AIS) is a heterogeneous condition. At the milder end of the clinical spectrum, patients with mild AIS (MAIS) are phenotypically male, and may present with infertility, either isolated or associated with gynaecomastia or signs of mild undervirilization. Most cases of complete and approximately 25% of partial AIS patients harbour mutations in the androgen receptor (AR) gene. Over 1,000 pathogenic variants have been describe...

ea0086p90 | Neuroendocrinology and Pituitary | SFEBES2022

Phosphoproteomics analysis of aryl hydrocarbon receptor interacting protein (AIP) knockout cells reveals AIP-mediated kinase signalling cascades

Barry Sayka , Rai Ashutosh , Haworth Haworth Oliver , Rajeeve Vinothini , Cutillas Pedro , Korbonits Marta

Introduction: Aryl hydrocarbon receptor interacting protein (AIP) is a multifunctional co-chaperone protein: it behaves as a tumour suppressor in the pituitary, but may have other roles including oncogenic function in other tissues. Protein phosphorylation is an important posttranslational modification that regulates protein activity, which is crucial for understanding protein function. To understand the molecular pathways altered in AIP deficient cells, we have performed glob...

ea0086p239 | Neuroendocrinology and Pituitary | SFEBES2022

A zebrafish model of AIP loss of function

Wang Xian , Leggieri Adele , Anagianni Sofia , Brennan Caroline H. , Korbonits Marta

Background: Aryl hydrocarbon receptor-interacting protein (AIP) has been identified as a tumour suppressor gene in pituitary gland, causing 10% of all familial isolated pituitary adenoma. Patients with heterozygous loss-of-function germline mutation of AIP develop young-onset growth hormone and/or prolactin-secreting pituitary tumours. Homozygous loss of AIP leads to embryonic lethality in several animal models (mouse, fruit fly, round worm). Mouse e...

ea0067o36 | Oral Presentations | EYES2019

Unusual cause of gigantism – Growth hormone releasing hormone (GHRH)-secreting pancreatic neuroendocrine tumour in a patient with multiple endocrine neoplasia type 1 (MEN1)

Nadhamuni Vinaya Srirangam , Iacovazzo Donato , Evanson Jane , Trouillas Jacqueline , Kurzawinski Tom , Bhattacharya Satya , Korbonits Marta

Background: Gigantism is a rare condition with accelerated growth in childhood when the epiphyseal plates are not fused. Most cases are due to growth hormone (GH) secretion from a pituitary adenoma. Rarer causes of GH-related gigantism include somatotroph hyperplasia as part of McCune-Albright syndrome, Carney complex, X-linked acrogigantism or ectopic GHRH production.Case presentation: An 18-year-old male with c.249_252delGTCT;p.I85Sfs MEN1 mut...

ea0063ep85 | Pituitary and Neuroendocrinology | ECE2019

The frequency of subclinical cushing’s syndrome in women with polycystic ovaries syndrome

Khalimova Zamira , Grossman Ashley , Levy Miles , Korbonits Marta , Pankiv Vladimir , Urmanova Yulduz

Aim: The aim of investigation to study of the features of the Cushing’s subclinical syndrome in women (CS) with metabolic syndrome (MS)Material and methods: Under our supervision in the Department of neuroendocrinology of the Center of Endocrinology of MPH out-patient clinics with primary or secondary infertility in the period from September 2015 to July 2016 were examined 120 patients of childbearing age with metabolic syndrome in polycystic ovary ...

ea0044p156 | Neuroendocrinology and pituitary | SFEBES2016

The role of the microenvironment in the invasive phenotype of familial pituitary tumours

Barry Sayka , Carlsen Eivind , Gadaleta Emanuela , Berney Dan , Chelala Claude , Crnogorac-Jurcevic Tatjana , Korbonits Marta

Background: Patients with heterozygote germline mutations in the aryl-hydrocarbon receptor interacting protein (AIP) gene (AIPpos) develop often aggressively growing tumours in early teenage years. The mechanism of this behaviour is not clear.Aim: The role of the microenvironment in the invasive phenotype of AIPpos pituitary tumours.Methods and results: We established that AIPpos GH-secreting tumours are infiltrated by a large numb...